Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Telaprevir'

Telaprevir published presentations and documents on DocSlides.

Telaprevir BID versus q8 in Treatment Naïve GT-1
Telaprevir BID versus q8 in Treatment Naïve GT-1
by volatilenestle
OPTIMIZE (. Study . C211). Phase . 3. Treatment. ...
Telaprevir
Telaprevir
by karlyn-bohler
BID versus q8 in Treatment Naïve GT-1. OPTIMIZE ...
Telaprevir in Treatment
Telaprevir in Treatment
by liane-varnes
Naïve GT-1. ILLUMINATE (Study 111). Phase . 3. T...
Telaprevir in Treatment
Telaprevir in Treatment
by marina-yarberry
Naïve GT-1. ADVANCE (Study 108). Phase . 3. Trea...
Practical management of PI therapy
Practical management of PI therapy
by TropicalParadise
in Hepatitis C . Paris . Februari. 2012. Ola . We...
Christophe Hézode Hôpital Henri Mondor,
Christophe Hézode Hôpital Henri Mondor,
by isabella
Créteil, France. Paris, 30 January 2012. Triple t...
Edited by
Edited by
by lindy-dunigan
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
Are (exogenous) interferons
Are (exogenous) interferons
by amey
really necessary?. Peter . Ferenci. Medical Univer...
HIV-HCV Coinfection in the era of effective antiviral therapy
HIV-HCV Coinfection in the era of effective antiviral therapy
by mia
Mark Sulkowski, . MD. Professor of Medicine. Medic...
Updates in Treatment of Hepatitis C
Updates in Treatment of Hepatitis C
by myesha-ticknor
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
Updates in Treatment of Hepatitis C
Updates in Treatment of Hepatitis C
by cheryl-pisano
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
AIDS CARE GROUP Grace Paik, CRNP
AIDS CARE GROUP Grace Paik, CRNP
by marina-yarberry
Regina . Ubaldi. -Rosen, CRNP. ELLAH NOTA, CRNP. ...
Simeprevir
Simeprevir
by alida-meadow
versus . Telaprevir. . with PR in GT1 . ATTAIN ...
DermatologicalsideeffectsofhepatitisCanditstreatment:Patientmanagement
DermatologicalsideeffectsofhepatitisCanditstreatment:Patientmanagement
by karlyn-bohler
JournalofHepatologyvol.56 Keywords:HCV;HepattitisC...
Reddy KR. Lancet Infect Dis. 2015;15:27-35
Reddy KR. Lancet Infect Dis. 2015;15:27-35
by natalia-silvester
ATTAIN. SMV + TVR placebo. + PEG-IFN + RBV. TVR ...
David Fletcher, MD
David Fletcher, MD
by tatiana-dople
Department of Medicine. University of Toronto. Co...
Management of HCV in Co-Infected Patients
Management of HCV in Co-Infected Patients
by danika-pritchard
Marie-Louise Vachon, MD, . MSc. Division of . Inf...
Edited by
Edited by
by celsa-spraggs
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
Update on the HCV Antiviral Pipeline
Update on the HCV Antiviral Pipeline
by natalia-silvester
Todd S. Wills, MD. SPNS HCV Treatment Expansion I...
Current strategies for the management of treatment naïve a
Current strategies for the management of treatment naïve a
by min-jolicoeur
Mark S. Sulkowski, MD. Medical Director, Viral He...